## Core Concept
Drug resistance in Tuberculosis (TB) primarily arises due to genetic mutations in the Mycobacterium tuberculosis complex. These mutations can occur spontaneously or under the selective pressure of anti-tubercular therapy. The most common mechanism involves mutations in specific genes that encode targets of anti-TB drugs.

## Why the Correct Answer is Right
The correct answer, **C. Genetic mutation**, is right because the primary mechanism of drug resistance in TB is the development of genetic mutations. These mutations can occur in genes such as *rpoB* (for rifampicin resistance), *katG* (for isoniazid resistance), and others. When these mutations occur, the bacteria become less susceptible to the drugs that target the proteins encoded by these genes. For example, mutations in the *rpoB* gene can lead to changes in the RNA polymerase enzyme, making it less susceptible to inhibition by rifampicin.

## Why Each Wrong Option is Incorrect
- **Option A: Overuse of antibiotics** - While the overuse or misuse of antibiotics can contribute to the development and spread of drug-resistant TB by applying selective pressure, it is not the direct cause of drug resistance. The direct cause is the genetic mutation that occurs within the bacteria.
- **Option B: Horizontal gene transfer** - Horizontal gene transfer is a process where bacteria share genes with each other outside of vertical inheritance. While this can contribute to the spread of resistance genes among bacteria, it is not the primary mechanism by which drug resistance arises in M. tuberculosis.
- **Option D: All of the above** - Since not all options provided are correct explanations for the primary cause of drug resistance in TB, this option cannot be correct.

## Clinical Pearl / High-Yield Fact
A key point to remember is that drug-resistant TB, especially multidrug-resistant TB (MDR-TB), poses a significant challenge to TB control programs. MDR-TB is defined by resistance to at least both rifampicin and isoniazid, the two most powerful first-line anti-TB drugs. The emergence of extensively drug-resistant TB (XDR-TB), which is MDR-TB plus resistance to any fluoroquinolone and at least one of three injectable second-line drugs, further complicates treatment.

## Correct Answer: C. Genetic mutation